Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PPROM-AZM Study
jRCTs031210631Completed
- Sponsor
- Japan Agency for Medical Research and Development
- Start
- Sep 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of azithromycin in Preterm prelabor rupture of membranes (PPROM), bronchopulmonary dysplasia (BPD), intraamniotic infection (IAI) and 1 more (2 arms), sponsored by Japan Agency for Medical Research and Development. Started Sep 2022; status: completed.
02
Drugs
azithromycin
03
Conditions
Preterm prelabor rupture of membranes (PPROM)bronchopulmonary dysplasia (BPD)intraamniotic infection (IAI)Perinatal infection
Beyond the preview
Go deeper on jRCTs031210631.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031210631.